Multiplex analysis of cytokines in the serum and cerebrospinal fluid of patients with Alzheimer's disease by color-coded bead technology
- PMID: 19513308
- PMCID: PMC2686871
- DOI: 10.3988/jcn.2008.4.2.84
Multiplex analysis of cytokines in the serum and cerebrospinal fluid of patients with Alzheimer's disease by color-coded bead technology
Abstract (VSports app下载)
Background and purpose: The availability and promise of effective treatments for neurodegenerative disorders are increasing the importance of early diagnosis. Having molecular and biochemical markers of Alzheimer's disease (AD) would complement clinical approaches, and further the goals of early and accurate diagnosis. Combining multiple biomarkers in evaluations significantly increases the sensitivity and specificity of the biochemical tests. VSports手机版.
Methods: In this study, we used color-coded bead-based Luminex technology to test the potential of using chemokines and cytokines as biochemical markers of AD. We measured the levels of 22 chemokines and cytokines in the serum and cerebrospinal fluid (CSF) of 32 de novo patients (13 controls, 11 AD, and 8 Parkinson's disease [PD]) V体育安卓版. .
Results: MCP-1 was the only cytokine detectable in CSF, and its levels did not differ between control and disease groups V体育ios版. However, the serum concentration of eotaxin was significantly higher in AD patients than in the control group. .
Conclusions: The analysis of multiple inflammatory mediators revealed marginal differences in their CSF and serum concentrations for the differential diagnosis of AD and PD VSports最新版本. These results provide evidence that immunological responses are not major contributors to the pathogenesis of AD and PD. .
Keywords: Alzheimer's disease; Biomarker; Cerebrospinal fluid; Neurodegeneration; Serum. V体育平台登录.
References
-
- Vellas B, Andrieu S, Sampaio C, Wilcock G European Task Force group. Disease-modifying trials in Alzheimer's disease: a European task force consensus. Lancet Neurol. 2007;6:56–62. - PubMed
-
- Mayeux R. Evaluation and use of diagnostic tests in Alzheimer's disease. Neurobiol Aging. 1998;19:139–143. - PubMed
-
- The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the The National Institute on Aging Working Group. Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". Neurobiol Aging. 1998;19:109–116. - V体育安卓版 - PubMed
-
- Kahle PJ, Jakowec M, Teipel SJ, Hampel H, Petzinger GM, Di Monte DA, et al. Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF. Neurology. 2000;54:1498–1504. - PubMed
-
- Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B, et al. Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau(Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem. 2005;51:336–345. - "VSports在线直播" PubMed
LinkOut - more resources
V体育2025版 - Full Text Sources
Miscellaneous
